StockData
Apyx Medical Corp logo

Apyx Medical Corp (APYX) stock

APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/3035% above fair value
$2.89−0.11 (-3.67%)

Close on Nov 12, 2026Market cap $121.74MP/E –Yield –

Apyx Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Apyx Medical's price to sales ratio was 2.2× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 0.8× to 10.2×, with a median of 2.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.2×−0.6
2025Dec 31, 20252.8×+1.6
2024Dec 31, 20241.1×−0.7
2023Dec 29, 20231.8×+0.1
2022Dec 30, 20221.7×−8.5
2021Dec 31, 202110.2×+0.2
2020Dec 31, 202010.0×−1.2
2019Dec 31, 201911.2×−3.9
2018Dec 31, 201815.1×+9.8
2017Dec 29, 20175.3×+2.6
2016Dec 30, 20162.8×+0.8
2015Dec 31, 20152.0×−0.5
2014Dec 31, 20142.5×+0.9
2013Dec 31, 20131.6×−0.0
2012Dec 31, 20121.6×+0.1
2011Dec 30, 20111.5×−0.6
2010Dec 31, 20102.1×–

More Apyx Medical figures

See a number that looks wrong?